» Articles » PMID: 26496547

Small (< 4 Cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT

Overview
Specialties Oncology
Radiology
Date 2015 Oct 27
PMID 26496547
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The purpose of this study was to evaluate whether small (< 4 cm) oncocytomas can be differentiated from renal cell carcinomas (RCCs) on biphasic contrast-enhanced CT.

Materials And Methods: Forty-three patients with 53 oncocytomas and 123 patients with 128 RCCs (24 papillary subtype and 104 clear cell and other subtypes) who underwent biphasic contrast-enhanced CT were included in the study. Patient demographics and CT tumor characteristics were evaluated in each case. A multinomial logistic regression model was then constructed for differentiating oncocytoma from clear cell and other subtype RCCs, oncocytoma from papillary RCCs, and clear cell and other subtype RCCs from papillary RCCs. The probability of each group was calculated from the model. Diagnostic performance among three pairwise diagnoses and between oncocytoma and any RCC (clear cell and other subtypes and papillary) were assessed by AUC values.

Results: Patient age, tumor CT attenuation values and skewness (i.e., histogram analysis of CT values) in both the corticomedullary and nephrographic phases, and subjective tumor heterogeneity were statistically significant variables in the multinomial logistic regression analysis. The logistic regression model using the variables yielded AUCs of 0.82, 0.95, 0.91, and 0.84 for differentiating oncocytomas from clear cell and other subtype RCCs, oncocytomas from papillary RCCs, clear cell and other subtype RCCs from papillary RCCs, and oncocytomas from any RCC (clear cell and other subtypes and papillary), respectively.

Conclusion: A combination of imaging features on biphasic CT, including tumor CT attenuation values and tumor texture (heterogeneity and skewness), can help differentiate oncocytoma from RCC.

Citing Articles

Radiomics and machine learning for renal tumor subtype assessment using multiphase computed tomography in a multicenter setting.

Uhlig A, Uhlig J, Leha A, Biggemann L, Bachanek S, Stockle M Eur Radiol. 2024; 34(10):6254-6263.

PMID: 38634876 PMC: 11399155. DOI: 10.1007/s00330-024-10731-6.


Low-grade oncocytic tumor: a review of radiologic and clinical features.

Chai J, Siegmund S, Hirsch M, Silverman S Abdom Radiol (NY). 2024; 49(6):1940-1948.

PMID: 38372764 DOI: 10.1007/s00261-023-04167-7.


Multiphase CT radiomics nomogram for preoperatively predicting the WHO/ISUP nuclear grade of small (< 4 cm) clear cell renal cell carcinoma.

Gao Y, Wang X, Zhao X, Zhu C, Li C, Li J BMC Cancer. 2023; 23(1):953.

PMID: 37814228 PMC: 10561466. DOI: 10.1186/s12885-023-11454-5.


A pilot radiometabolomics integration study for the characterization of renal oncocytic neoplasia.

Klontzas M, Koltsakis E, Kalarakis G, Trpkov K, Papathomas T, Sun N Sci Rep. 2023; 13(1):12594.

PMID: 37537362 PMC: 10400617. DOI: 10.1038/s41598-023-39809-9.


Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review.

Ferro M, Crocetto F, Barone B, Del Giudice F, Maggi M, Lucarelli G Ther Adv Urol. 2023; 15:17562872231164803.

PMID: 37113657 PMC: 10126666. DOI: 10.1177/17562872231164803.